JW PHARMACEUTICAL Q3 operating profit KRW 29.0 billion, down 9.6% from a year earlier
AI summary · Not investment advice
In Q3, the company sold KRW 212.1 billion and earned KRW 29.0 billion from its main business, down 9.6% from a year earlier and 13.2% from the prior quarter.
Operating profit · 3 months
KRW 29.0 billion
Key facts
- Revenue (3 months)
- KRW 212.1 billion
- Net income (3 months)
- KRW 20.2 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 200.0 billion
- Revenue (year to date)
- KRW 634.0 billion
- Operating profit (prior-year 3 months)
- KRW 32.0 billion
- Operating profit (year to date)
- KRW 95.9 billion
- Net income (prior-year 3 months)
- KRW 30.6 billion
- Net income (year to date)
- KRW 75.6 billion
Commentary
AI commentary · Not investment advice
What happened
JW Chungwae Pharmaceutical filed its quarterly report with consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 212.07 billion. That is 6.0% higher than the same 3 months a year earlier. It is 4.5% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 28.95 billion. That is 9.6% lower than a year earlier and 13.2% lower than the previous quarter. The year-earlier figure was KRW 32.03 billion.
What changes for shareholders
Net income (the final profit after taxes and other costs) for the 3 months was KRW 20.20 billion. That is 34.0% lower than a year earlier and 27.6% lower than the previous quarter. The year-earlier figure was KRW 30.59 billion.
For the year to date, from January 1 to September 30, sales were KRW 633.97 billion. Operating profit was KRW 95.87 billion. Net income was KRW 75.75 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
J